A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Phase 1/2 Recruiting
12 enrolled
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
Phase 1 Recruiting
60 enrolled
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Recruiting
1,263 enrolled
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Phase 1 Recruiting
12 enrolled
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Phase 1 Recruiting
280 enrolled
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Phase 1 Recruiting
20 enrolled
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Phase 2 Recruiting
115 enrolled
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Recruiting
1,250 enrolled
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Phase 2 Recruiting
44 enrolled
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
Phase 2 Recruiting
23 enrolled
Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
Phase 1 Recruiting
38 enrolled
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Recruiting
200 enrolled
Amping up With PemJAK
Phase 2 Recruiting
53 enrolled
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
Phase 2 Recruiting
20 enrolled
FIL_CTCL
Recruiting
400 enrolled
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Phase 2 Recruiting
48 enrolled
FLASH2
Phase 3 Recruiting
80 enrolled
Tissue Repository: CTCL Collection Protocol
Recruiting
400 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Phase 2 Recruiting
34 enrolled
Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 Recruiting
46 enrolled
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
Phase 1 Recruiting
50 enrolled
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Phase 1 Recruiting
127 enrolled
Photopheresis in Early-stage Mycosis Fungoides
Phase 2 Recruiting
74 enrolled
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Phase 1 Recruiting
46 enrolled
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Phase 1 Recruiting
10 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Phase NA Recruiting
40 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
Phase 1/2 Recruiting
36 enrolled
A Registry for People With T-cell Lymphoma
Recruiting
1,000 enrolled
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
Phase 1/2 Recruiting
36 enrolled
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Phase 2 Recruiting
32 enrolled
BIO-MUSE
Recruiting
120 enrolled
MORPHEE
Phase NA Recruiting
20 enrolled
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Phase NA Recruiting
20 enrolled
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
Recruiting
150 enrolled
AMITY
Recruiting
100 enrolled
MOGAT
Phase 2 Recruiting
43 enrolled
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
Recruiting
300 enrolled
TACTICAL
Recruiting
3,000 enrolled